N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases

Details for Australian Patent Application No. 2004265243 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Chen, Rita; Tsai, James; Smith, Brian

Agent FB Rice

Pub. Number AU-A-2004265243

PCT Pub. Number WO2005/016902

Priority 60/480,045 20.06.03 US

Filing date 17 June 2004

Wipo publication date 24 February 2005

International Classifications

C07D 295/06 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/016902 Priority application(s): WO2005/016902

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265249-Methods and systems for processing microscale devices for reuse

2004265238-Treatment of lung cancer with active vitamin D compounds in combination with other treatments